Search | IOVS | ARVO Journals

Showing 1 – 20 of 24

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Imaging in the Eye Conference Abstract July 2020

Evaluating the long-term effects of anti-vascular endothelial growth factor therapy on choroidal neovascularization in age-related macular degeneration using optical coherence tomography angiography

Emily Levine; Eugenia Paula Custo Greig; Luisa Mendonca; Shilpa Gulati; Ivana Despotovic; Eric Moult; James Fujimoto; Adil El-Maftouhi; Maddalena Quaranta-el Maftouhi; Nora Muakkassa; Caroline Baumal; Andre Witkin; Jay Duker; Nadia Waheed

Invest. Ophthalmol. Vis. Sci.. 2020; 61(9):PB0025.

ARVO Annual Meeting Abstract June 2017

Evaluation of time-to-recurrence of disease activity in treatment-naïve patients with neovascular age-related macular degeneration after ranibizumab treatment: 12-month analysis from the ORACLE study

Maddalena Quaranta; François DEVIN; Gabriel QUENTEL; Joël UZZAN; Eric Fourmaux; Laurent CASTELNOVO; Wilfried ROQUET; Catherine FRANCAIS-MAURY; Sam RAZAVI; Nathalie San Nicolas

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):900.

ARVO Annual Meeting Abstract September 2016

Change in Pigment Epithelial Detachment Volume and its Relationship with Subretinal Fluid and Visual Acuity in Patients with Exudative AMD after Aflibercept Switch Therapy. Post hoc analysis from the ARI2 Study.

Camille JUNG; Rocio Blanco-Garavito; Oudy Semoun; Joel Uzzan; Florence Coscas; Maddalena Quaranta-El Maftouhi; Jose Sahel; Jean-Francois Korobelnik; Nathalie Puche; Giuseppe Querques; Eric H Souied

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):519.

ARVO Annual Meeting Abstract September 2016

A Phase III b, Multicenter Study of the Efficacy and Safety of Aflibercept Switch in Patients With Exudative AMD With Retinal Pigment Epithelium Detachment, Previously Treated With Ranibizumab Intravitreal Injections. The ARI2 Study.

Rocio Blanco-Garavito; Camille JUNG; Joel Uzzan; Florence Coscas; Maddalena QUARANTA EL-MAFTOUHI; Jose Sahel; Jean-Francois Korobelnik; Ruxandra HERA; Giuseppe Querques; Oudy Semoun; Eric H Souied

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):528.

ARVO Annual Meeting Abstract September 2016

Time to recurrence in neovascular age-related macular degeneration after ranibizumab treatment: baseline characteristics of treatment-naive patients enrolled in the ORACLE study

François Devin; Eric Fourmaux; gabriel quentel; Joel Uzzan; Maddalena QUARANTA EL-MAFTOUHI; Catherine Français-Maury; Wilfried Roquet; Laurent Castelnovo; Sam Razavi; Laetitia Finzi

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3353.

ARVO Annual Meeting Abstract September 2016

A Comparison of Optical Coherence Tomography Angiography to Fluorescein Angiography for the Imaging of Type 1 Neovascularization

Maiko Inoue; Jesse J Jung; Chandra Bala; Talisa E de Carlo; Abtin Shahlaee; Michael A Klufas; Jay S Duker; Allen C Ho; Maddalena QUARANTA EL-MAFTOUHI; David Sarraf; K Bailey Freund

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12)

Articles July 2016

A Comparison Between Optical Coherence Tomography Angiography and Fluorescein Angiography for the Imaging of Type 1 Neovascularization

PDF

Maiko Inoue; Jesse J. Jung; Chandrakumar Balaratnasingam; Kunal K. Dansingani; Elona Dhrami-Gavazi; Mihoko Suzuki; Talisa E. de Carlo; Abtin Shahlaee; Michael A. Klufas; Adil El Maftouhi; Jay S. Duker; Allen C. Ho; Maddalena Quaranta-El Maftouhi; David Sarraf; K. Bailey Freund; for the COFT-1 Study Group
TAGS: angiogram, diagnostic imaging, face, fluorescein angiography, neovascularization, pathologic, optical coherence tomography, eye
Invest. Ophthalmol. Vis. Sci.. 2016; 57(9):OCT314-OCT323. https://doi.org/10.1167/iovs.15-18900

ARVO Annual Meeting Abstract June 2015

Ranibizumab and exudative age-related macular degeneration: five years multicentric functional and anatomical results in real-life practice in France.

Elise Boulanger-Semama; David Sayag; Thi Ha Chau Tran; Maddalena Quaranta-El Maftouhi; Franck Rumen; Catherine P Garcher; Camille Jung; Rocio Blanco-Garavito; Eric H Souied

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5353.

ARVO Annual Meeting Abstract April 2014

Switch from aflibercept to ranibizumab: Up to 2 years follow-up post View2 study

Maddalena Quaranta; Francois Devin

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3935.

ARVO Annual Meeting Abstract April 2010

Retinal Cysts in Age-Related Macular Degeneration: An Oct Study

B. Wolff; M. Quaranta El Maftouhi; M. Mauget Faÿsse

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):4929.

ARVO Annual Meeting Abstract May 2008

Anti-VEGF Intravitreal Injections for Myopic Choroidal Neovascularization

M. El Maftouhi-Quaranta; M. Mauget-Faÿsse

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5584.

ARVO Annual Meeting Abstract May 2006

Photodynamic Therapy in the Treatment of Choroidal Metastasis From a Lung Adenocarcinoma

M. Mauget–Faysse; M. Quaranta–El Maftouhi; J. Gambrelle

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4710.

ARVO Annual Meeting Abstract May 2006

Retrospective Analysis of OCT Signs Predicting Retinal Pigment Epithelial Rip in AMD

M. Quaranta–El; A. El Maftouhi; M. Mauget Faÿsse

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2156.

ARVO Annual Meeting Abstract May 2006

Pachymetry of Corneal Flap by OCT 3

A. El Maftouhi–Quaranta; M. Puech; R. Amar; D. Lebuisson

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1332.

ARVO Annual Meeting Abstract May 2005

Evolutional Classification of Idiopathic Polypoidal Choroidal Vasculopathy According to Fluorescein Angiographic and OCT Findings

M. Quaranta; M. Mauget–Faÿsse

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):226.

ARVO Annual Meeting Abstract May 2005

Verteporfin Photodynamic Therapy (PDT) of CNV Associated With Toxoplasma Retinochoroiditis

A.M. Leys; M. Mauget–Faÿsse; G. Mimoun; J.M. Ruiz–Moreno; M. Quaranta; G. Soubrane; L. Postelmans; M. Defauchy; J.J. De Laey

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):341.

ARVO Annual Meeting Abstract May 2004

Photodynamic therapy with verteporfin for idiopathic polypoidal choroidal vasculopathy. Preliminary results.

M. Mauget–Faysse; M. Quaranta; A. Leys; E. de La Marnierre

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):5268.

ARVO Annual Meeting Abstract May 2004

Diagnostic and prognostic interest of OCT for Occult Neovascularization secondary to AMD treated by Photodynamic Therapy with Visudyne

M. Quaranta; M. Mauget–Faÿsse; E. de La Marnierre

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):3168.

Biochemistry and Molecular Biology August 2003

Idiopathic and Radiation-Induced Ocular Telangiectasia: The Involvement of the ATM Gene

PDF

Martine Mauget-Faÿsse; Michèle Vuillaume; Maddalena Quaranta; Norman Moullan; Sandra Angèle; Marlin D. Friesen; Janet Hall
TAGS: atm gene, radiation, telangiectasis
Invest. Ophthalmol. Vis. Sci.. 2003; 44(8):3257-3262. https://doi.org/10.1167/iovs.02-1269

ARVO Annual Meeting Abstract May 2003

Vitreo-retinal Anomalous Adherences in Patients with Exudative AMD : An OCT Study

M. Quaranta; M. Mauget-Faÿsse

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):1824.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Evaluating the long-term effects of anti-vascular endothelial growth factor therapy on choroidal neovascularization in age-related macular degeneration using optical coherence tomography angiography

Evaluation of time-to-recurrence of disease activity in treatment-naïve patients with neovascular age-related macular degeneration after ranibizumab treatment: 12-month analysis from the ORACLE study

Change in Pigment Epithelial Detachment Volume and its Relationship with Subretinal Fluid and Visual Acuity in Patients with Exudative AMD after Aflibercept Switch Therapy. Post hoc analysis from the ARI2 Study.

A Phase III b, Multicenter Study of the Efficacy and Safety of Aflibercept Switch in Patients With Exudative AMD With Retinal Pigment Epithelium Detachment, Previously Treated With Ranibizumab Intravitreal Injections. The ARI2 Study.

Time to recurrence in neovascular age-related macular degeneration after ranibizumab treatment: baseline characteristics of treatment-naive patients enrolled in the ORACLE study

A Comparison of Optical Coherence Tomography Angiography to Fluorescein Angiography for the Imaging of Type 1 Neovascularization

A Comparison Between Optical Coherence Tomography Angiography and Fluorescein Angiography for the Imaging of Type 1 Neovascularization

Ranibizumab and exudative age-related macular degeneration: five years multicentric functional and anatomical results in real-life practice in France.

Switch from aflibercept to ranibizumab: Up to 2 years follow-up post View2 study

Retinal Cysts in Age-Related Macular Degeneration: An Oct Study

Anti-VEGF Intravitreal Injections for Myopic Choroidal Neovascularization

Photodynamic Therapy in the Treatment of Choroidal Metastasis From a Lung Adenocarcinoma

Retrospective Analysis of OCT Signs Predicting Retinal Pigment Epithelial Rip in AMD

Pachymetry of Corneal Flap by OCT 3

Evolutional Classification of Idiopathic Polypoidal Choroidal Vasculopathy According to Fluorescein Angiographic and OCT Findings

Verteporfin Photodynamic Therapy (PDT) of CNV Associated With Toxoplasma Retinochoroiditis

Photodynamic therapy with verteporfin for idiopathic polypoidal choroidal vasculopathy. Preliminary results.

Diagnostic and prognostic interest of OCT for Occult Neovascularization secondary to AMD treated by Photodynamic Therapy with Visudyne

Idiopathic and Radiation-Induced Ocular Telangiectasia: The Involvement of the ATM Gene

Vitreo-retinal Anomalous Adherences in Patients with Exudative AMD : An OCT Study

To View More...

You must be signed into an individual account to use this feature.